Table 1:

Demography and intraoperative details

CharacteristicRandomized to ICBC (n = 48), n (%)Randomized to IWBC (n = 49), n (%)Overall (n = 97), n (%)
Demography
 Age (years), median (IQR)0.9 (0.3–5.2)1.5 (0.3–4.0)1.2 (0.3–4.4)
 Female12/48 (25.0%)22/49 (44.9%)34/97 (35.1%)
 Body mass index, median (IQR)16.1 (14.2–17.9)15.6 (14.0–17.0)15.8 (14.2–17.5)
 Body surface area (m2),a median (IQR)0.4 (0.3–0.8)0.5 (0.3–0.7)0.5 (0.3–0.7)
Procedure
 Ross4/48 (8.3%)1/49 (2.0%)5/97 (5.2%)
 Pulmonary pathway procedure6/48 (12.5%)5/49 (10.2%)11/97 (11.3%)
 Ventricular septal defect ± atrial septal defect ± pulmonary artery debanding9/48 (18.8%)8/49 (16.3%)17/97 (17.5%)
 Arterial switch ± ventricular septal defect2/48 (4.2%)2/49 (4.1%)4/97 (4.1%)
 Tetralogy of Fallot repair4/48 (8.3%)8/49 (16.3%)12/97 (12.4%)
 Atrioventricular valve repair/replacement3/48 (6.3%)4/49 (8.2%)7/97 (7.2%)
 Atrioventricular septal defect8/48 (16.7%)7/49 (14.3%)15/97 (15.5%)
 Double outlet right ventricle2/48 (4.2%)0/49 (0.0%)2/97 (2.1%)
 Partial or total anomalous pulmonary venous drainage0/48 (0.0%)3/49 (6.1%)3/97 (3.1%)
 Rastelli-type procedure1/48 (2.1%)2/49 (4.1%)3/97 (3.1%)
 Subaortic stenosis repair6/48 (12.5%)4/49 (8.2%)10/97 (10.3%)
 Otherb3/48 (6.3%)5/49 (10.2%)8/97 (8.2%)
RACHS score
 1–218/48 (37.5%)20/49 (40.8%)38/97 (39.2%)
 3+30/48 (62.5%)29/49 (59.2%)59/97 (60.8%)
Preoperative left or right ventricular dysfunction8/31 (25.8%)4/31 (12.9%)12/62 (19.4%)
Bypass data
 Duration of bypass (min),c median (IQR)101 (77.0–154.0)96 (67.0, 136.0)100 (69.5–146.0)
 Duration of cross-clamp (min),c,d median (IQR)72 (43.0–137.0)69 (39.0–100.0)70 (43.0–108.0)
 Mean core temperature while cross-clamp on (°C),e median (IQR)34.0 (32.3–34.8)34.8 (32.7–35.3)34.0 (32.5–35.0)
 Cardioversion5/48 (10.4%)1/49 (2.0%)6/97 (6.2%)
 Defibrillation3/48 (6.3%)2/49 (4.1%)5/97 (5.2%)
 Ischaemic changes coming off CPB3/43 (7.0%)3/47 (6.4%)6/90 (6.7%)
 Lowest haematocrit during surgery (%),a median (IQR)0.28 (0.26–0.29)0.27 (0.26–0.29)0.27 (0.26–0.29)
 Modified ultrafiltration18/47 (38.3%)22/49 (44.9%)40/96 (41.7%)
  Volume (ml), median (IQR)200 (180–210)235 (200–300)200 (190–260)
Cardioplegia
 Intervention receivedc46/46 (100%)49/49 (100%)95/95 (100%)
 Temperature of first infusion (°C),f median (IQR)4.0 (4.0–4.6)34.4 (34.0–35.0)
 Temperature of second infusion (°C),g median (IQR)4.0 (4.0–4.7)34.2 (34.0–35.0)
 Third infusion needed20/47 (42.6%)35/49 (71.4%)55/96 (57.3%)
 Temperature of third infusion, if needed (°C),h median (IQR)4.0 (3.8–4.2)34.4 (34.0–35.1)
CharacteristicRandomized to ICBC (n = 48), n (%)Randomized to IWBC (n = 49), n (%)Overall (n = 97), n (%)
Demography
 Age (years), median (IQR)0.9 (0.3–5.2)1.5 (0.3–4.0)1.2 (0.3–4.4)
 Female12/48 (25.0%)22/49 (44.9%)34/97 (35.1%)
 Body mass index, median (IQR)16.1 (14.2–17.9)15.6 (14.0–17.0)15.8 (14.2–17.5)
 Body surface area (m2),a median (IQR)0.4 (0.3–0.8)0.5 (0.3–0.7)0.5 (0.3–0.7)
Procedure
 Ross4/48 (8.3%)1/49 (2.0%)5/97 (5.2%)
 Pulmonary pathway procedure6/48 (12.5%)5/49 (10.2%)11/97 (11.3%)
 Ventricular septal defect ± atrial septal defect ± pulmonary artery debanding9/48 (18.8%)8/49 (16.3%)17/97 (17.5%)
 Arterial switch ± ventricular septal defect2/48 (4.2%)2/49 (4.1%)4/97 (4.1%)
 Tetralogy of Fallot repair4/48 (8.3%)8/49 (16.3%)12/97 (12.4%)
 Atrioventricular valve repair/replacement3/48 (6.3%)4/49 (8.2%)7/97 (7.2%)
 Atrioventricular septal defect8/48 (16.7%)7/49 (14.3%)15/97 (15.5%)
 Double outlet right ventricle2/48 (4.2%)0/49 (0.0%)2/97 (2.1%)
 Partial or total anomalous pulmonary venous drainage0/48 (0.0%)3/49 (6.1%)3/97 (3.1%)
 Rastelli-type procedure1/48 (2.1%)2/49 (4.1%)3/97 (3.1%)
 Subaortic stenosis repair6/48 (12.5%)4/49 (8.2%)10/97 (10.3%)
 Otherb3/48 (6.3%)5/49 (10.2%)8/97 (8.2%)
RACHS score
 1–218/48 (37.5%)20/49 (40.8%)38/97 (39.2%)
 3+30/48 (62.5%)29/49 (59.2%)59/97 (60.8%)
Preoperative left or right ventricular dysfunction8/31 (25.8%)4/31 (12.9%)12/62 (19.4%)
Bypass data
 Duration of bypass (min),c median (IQR)101 (77.0–154.0)96 (67.0, 136.0)100 (69.5–146.0)
 Duration of cross-clamp (min),c,d median (IQR)72 (43.0–137.0)69 (39.0–100.0)70 (43.0–108.0)
 Mean core temperature while cross-clamp on (°C),e median (IQR)34.0 (32.3–34.8)34.8 (32.7–35.3)34.0 (32.5–35.0)
 Cardioversion5/48 (10.4%)1/49 (2.0%)6/97 (6.2%)
 Defibrillation3/48 (6.3%)2/49 (4.1%)5/97 (5.2%)
 Ischaemic changes coming off CPB3/43 (7.0%)3/47 (6.4%)6/90 (6.7%)
 Lowest haematocrit during surgery (%),a median (IQR)0.28 (0.26–0.29)0.27 (0.26–0.29)0.27 (0.26–0.29)
 Modified ultrafiltration18/47 (38.3%)22/49 (44.9%)40/96 (41.7%)
  Volume (ml), median (IQR)200 (180–210)235 (200–300)200 (190–260)
Cardioplegia
 Intervention receivedc46/46 (100%)49/49 (100%)95/95 (100%)
 Temperature of first infusion (°C),f median (IQR)4.0 (4.0–4.6)34.4 (34.0–35.0)
 Temperature of second infusion (°C),g median (IQR)4.0 (4.0–4.7)34.2 (34.0–35.0)
 Third infusion needed20/47 (42.6%)35/49 (71.4%)55/96 (57.3%)
 Temperature of third infusion, if needed (°C),h median (IQR)4.0 (3.8–4.2)34.4 (34.0–35.1)
a

Data missing for 1 patient (ICBC).

b

Other procedures were: ICBC group—double outlet right ventricle and partial anomalous pulmonary venous drainage repair, aortic root replacement, tricuspid valve repair and right ventricular myectomy. IWBC group—repair of double outlet right ventricle and atrioventricular septal defect and atrial switch (hemi-Mustard), tetralogy of Fallot and atrioventricular septal defect repair, mitral valve replacement and Ross-Konno, ventricular septal defect and Ebstein’s repair, pulmonary and tricuspid valve replacement.

c

Two patients (ICBC) withdrew prior to or during surgery.

d

Ranges (minimum–maximum): ICBC: 25–200 min, IWBC 16–292 min.

e

Data missing for 1 patient (IWBC).

f

Data missing for 6 patients (4 ICBC, 2 IWBC).

g

Data missing for 20 patients (13 ICBC, 7 IWBC).

h

Data missing for 2 patients (1 ICBC, 1 IWBC).

CPB: cardiopulmonary bypass; ICBC: intermittent cold blood cardioplegia; IQR: interquartile range; IWBC: intermittent warm blood cardioplegia; RACHS: Risk adjustment for Congenital Heart Surgery.

Table 1:

Demography and intraoperative details

CharacteristicRandomized to ICBC (n = 48), n (%)Randomized to IWBC (n = 49), n (%)Overall (n = 97), n (%)
Demography
 Age (years), median (IQR)0.9 (0.3–5.2)1.5 (0.3–4.0)1.2 (0.3–4.4)
 Female12/48 (25.0%)22/49 (44.9%)34/97 (35.1%)
 Body mass index, median (IQR)16.1 (14.2–17.9)15.6 (14.0–17.0)15.8 (14.2–17.5)
 Body surface area (m2),a median (IQR)0.4 (0.3–0.8)0.5 (0.3–0.7)0.5 (0.3–0.7)
Procedure
 Ross4/48 (8.3%)1/49 (2.0%)5/97 (5.2%)
 Pulmonary pathway procedure6/48 (12.5%)5/49 (10.2%)11/97 (11.3%)
 Ventricular septal defect ± atrial septal defect ± pulmonary artery debanding9/48 (18.8%)8/49 (16.3%)17/97 (17.5%)
 Arterial switch ± ventricular septal defect2/48 (4.2%)2/49 (4.1%)4/97 (4.1%)
 Tetralogy of Fallot repair4/48 (8.3%)8/49 (16.3%)12/97 (12.4%)
 Atrioventricular valve repair/replacement3/48 (6.3%)4/49 (8.2%)7/97 (7.2%)
 Atrioventricular septal defect8/48 (16.7%)7/49 (14.3%)15/97 (15.5%)
 Double outlet right ventricle2/48 (4.2%)0/49 (0.0%)2/97 (2.1%)
 Partial or total anomalous pulmonary venous drainage0/48 (0.0%)3/49 (6.1%)3/97 (3.1%)
 Rastelli-type procedure1/48 (2.1%)2/49 (4.1%)3/97 (3.1%)
 Subaortic stenosis repair6/48 (12.5%)4/49 (8.2%)10/97 (10.3%)
 Otherb3/48 (6.3%)5/49 (10.2%)8/97 (8.2%)
RACHS score
 1–218/48 (37.5%)20/49 (40.8%)38/97 (39.2%)
 3+30/48 (62.5%)29/49 (59.2%)59/97 (60.8%)
Preoperative left or right ventricular dysfunction8/31 (25.8%)4/31 (12.9%)12/62 (19.4%)
Bypass data
 Duration of bypass (min),c median (IQR)101 (77.0–154.0)96 (67.0, 136.0)100 (69.5–146.0)
 Duration of cross-clamp (min),c,d median (IQR)72 (43.0–137.0)69 (39.0–100.0)70 (43.0–108.0)
 Mean core temperature while cross-clamp on (°C),e median (IQR)34.0 (32.3–34.8)34.8 (32.7–35.3)34.0 (32.5–35.0)
 Cardioversion5/48 (10.4%)1/49 (2.0%)6/97 (6.2%)
 Defibrillation3/48 (6.3%)2/49 (4.1%)5/97 (5.2%)
 Ischaemic changes coming off CPB3/43 (7.0%)3/47 (6.4%)6/90 (6.7%)
 Lowest haematocrit during surgery (%),a median (IQR)0.28 (0.26–0.29)0.27 (0.26–0.29)0.27 (0.26–0.29)
 Modified ultrafiltration18/47 (38.3%)22/49 (44.9%)40/96 (41.7%)
  Volume (ml), median (IQR)200 (180–210)235 (200–300)200 (190–260)
Cardioplegia
 Intervention receivedc46/46 (100%)49/49 (100%)95/95 (100%)
 Temperature of first infusion (°C),f median (IQR)4.0 (4.0–4.6)34.4 (34.0–35.0)
 Temperature of second infusion (°C),g median (IQR)4.0 (4.0–4.7)34.2 (34.0–35.0)
 Third infusion needed20/47 (42.6%)35/49 (71.4%)55/96 (57.3%)
 Temperature of third infusion, if needed (°C),h median (IQR)4.0 (3.8–4.2)34.4 (34.0–35.1)
CharacteristicRandomized to ICBC (n = 48), n (%)Randomized to IWBC (n = 49), n (%)Overall (n = 97), n (%)
Demography
 Age (years), median (IQR)0.9 (0.3–5.2)1.5 (0.3–4.0)1.2 (0.3–4.4)
 Female12/48 (25.0%)22/49 (44.9%)34/97 (35.1%)
 Body mass index, median (IQR)16.1 (14.2–17.9)15.6 (14.0–17.0)15.8 (14.2–17.5)
 Body surface area (m2),a median (IQR)0.4 (0.3–0.8)0.5 (0.3–0.7)0.5 (0.3–0.7)
Procedure
 Ross4/48 (8.3%)1/49 (2.0%)5/97 (5.2%)
 Pulmonary pathway procedure6/48 (12.5%)5/49 (10.2%)11/97 (11.3%)
 Ventricular septal defect ± atrial septal defect ± pulmonary artery debanding9/48 (18.8%)8/49 (16.3%)17/97 (17.5%)
 Arterial switch ± ventricular septal defect2/48 (4.2%)2/49 (4.1%)4/97 (4.1%)
 Tetralogy of Fallot repair4/48 (8.3%)8/49 (16.3%)12/97 (12.4%)
 Atrioventricular valve repair/replacement3/48 (6.3%)4/49 (8.2%)7/97 (7.2%)
 Atrioventricular septal defect8/48 (16.7%)7/49 (14.3%)15/97 (15.5%)
 Double outlet right ventricle2/48 (4.2%)0/49 (0.0%)2/97 (2.1%)
 Partial or total anomalous pulmonary venous drainage0/48 (0.0%)3/49 (6.1%)3/97 (3.1%)
 Rastelli-type procedure1/48 (2.1%)2/49 (4.1%)3/97 (3.1%)
 Subaortic stenosis repair6/48 (12.5%)4/49 (8.2%)10/97 (10.3%)
 Otherb3/48 (6.3%)5/49 (10.2%)8/97 (8.2%)
RACHS score
 1–218/48 (37.5%)20/49 (40.8%)38/97 (39.2%)
 3+30/48 (62.5%)29/49 (59.2%)59/97 (60.8%)
Preoperative left or right ventricular dysfunction8/31 (25.8%)4/31 (12.9%)12/62 (19.4%)
Bypass data
 Duration of bypass (min),c median (IQR)101 (77.0–154.0)96 (67.0, 136.0)100 (69.5–146.0)
 Duration of cross-clamp (min),c,d median (IQR)72 (43.0–137.0)69 (39.0–100.0)70 (43.0–108.0)
 Mean core temperature while cross-clamp on (°C),e median (IQR)34.0 (32.3–34.8)34.8 (32.7–35.3)34.0 (32.5–35.0)
 Cardioversion5/48 (10.4%)1/49 (2.0%)6/97 (6.2%)
 Defibrillation3/48 (6.3%)2/49 (4.1%)5/97 (5.2%)
 Ischaemic changes coming off CPB3/43 (7.0%)3/47 (6.4%)6/90 (6.7%)
 Lowest haematocrit during surgery (%),a median (IQR)0.28 (0.26–0.29)0.27 (0.26–0.29)0.27 (0.26–0.29)
 Modified ultrafiltration18/47 (38.3%)22/49 (44.9%)40/96 (41.7%)
  Volume (ml), median (IQR)200 (180–210)235 (200–300)200 (190–260)
Cardioplegia
 Intervention receivedc46/46 (100%)49/49 (100%)95/95 (100%)
 Temperature of first infusion (°C),f median (IQR)4.0 (4.0–4.6)34.4 (34.0–35.0)
 Temperature of second infusion (°C),g median (IQR)4.0 (4.0–4.7)34.2 (34.0–35.0)
 Third infusion needed20/47 (42.6%)35/49 (71.4%)55/96 (57.3%)
 Temperature of third infusion, if needed (°C),h median (IQR)4.0 (3.8–4.2)34.4 (34.0–35.1)
a

Data missing for 1 patient (ICBC).

b

Other procedures were: ICBC group—double outlet right ventricle and partial anomalous pulmonary venous drainage repair, aortic root replacement, tricuspid valve repair and right ventricular myectomy. IWBC group—repair of double outlet right ventricle and atrioventricular septal defect and atrial switch (hemi-Mustard), tetralogy of Fallot and atrioventricular septal defect repair, mitral valve replacement and Ross-Konno, ventricular septal defect and Ebstein’s repair, pulmonary and tricuspid valve replacement.

c

Two patients (ICBC) withdrew prior to or during surgery.

d

Ranges (minimum–maximum): ICBC: 25–200 min, IWBC 16–292 min.

e

Data missing for 1 patient (IWBC).

f

Data missing for 6 patients (4 ICBC, 2 IWBC).

g

Data missing for 20 patients (13 ICBC, 7 IWBC).

h

Data missing for 2 patients (1 ICBC, 1 IWBC).

CPB: cardiopulmonary bypass; ICBC: intermittent cold blood cardioplegia; IQR: interquartile range; IWBC: intermittent warm blood cardioplegia; RACHS: Risk adjustment for Congenital Heart Surgery.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close